Avadomide (CC-122), a Novel Cereblon Modulating Agent, in Combination with Obinutuzumab (GA101) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共4页
• 作者

  Michot Jean-Marie; Bouabdallah Reda; Doorduijn Jeanette K.; Vitolo Umberto; Kersten Marie Jose; Chiappella Annalisa; Zinzani Pier Luigi; Salles Gilles; Bijou Fontanet; Sarmiento Rafael; Mosulen Silvia; Mendez Cristina; Uttamsingh Shailaja; Pourdehnad Michael; Hege Kristen; Li Li; Nikolova Zariana; Ribrag Vincent;

  展开▼
• 作者单位

  Inst Gustave Roussy Villejuif France;

  Inst Paoli Calmettes Marseille France;

  Erasmus MC Canc Inst Rotterdam Netherlands;

  Azienda Osped Univ Citta Salute &

  Sci Torino Turin Italy;

  Acad Med Ctr Amsterdam Netherlands;

  Azienda Osped Univ Citta Salute &

  Sci Torino Turin Italy;

  Univ Bologna Inst Hematol L &

  A Seragnoli Bologna Italy;

  Ctr Hosp Lyon Sud Pierre Benite France;

  Inst Bergonie Bordeaux France;

  Celgene Inst Translat Res Europe Seville Spain;

  Celgene Inst Translat Res Europe Seville Spain;

  Celgene Inst Translat Res Europe Seville Spain;

  Celgene Corp San Francisco CA USA;

  Celgene Corp San Francisco CA USA;

  Celgene Corp San Francisco CA USA;

  Celgene Corp Berkeley Hts NJ USA;

  Celgene Inst Translat Res Europe Seville Spain;

  Inst Gustave Roussy Villejuif France;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词